Semaglutide biosimilar is under clinical development by Leto Laboratories and currently in Phase II for Diabetes.

Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective ...

Three GLP-1 drugs are best at helping obese and overweight people drop weight, including one that hasn’t yet been ap ...

New findings on semaglutide and tirzepatide published in 2024 revealed that the medications may have benefits beyond lowering glucose levels and body weight.At the Cardiometabolic Health Congress in ...

Dignity Health January marks Healthy Weight Awareness Month, and with the new year, many are setting health and weight loss ...

Weight management platform Found is today launching oral semaglutide dissolvable tablets for individuals looking for ...

This year's top 5 most-read cardiovascular articles explored topics ranging from FDA approvals to the risks associated with ...

THURSDAY, Dec. 26, (2024 HealthDay News) -- The U.S. Food and Drug Administration (FDA) announced on Monday the approval of ...

Ozempic and Wegovy are two popular injectable medications for weight loss and diabetes. But what’s the difference?

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

"Because most people with obesity have elevated insulin levels, they develop insulin resistance, which contributes to weight gain. Semaglutide (or Ozempic) helps lower the levels of this fat-storing ...

The drug was tentatively approved in June by the FDA ... Scientific model of the molecule semaglutide which is the active ingredient in Novo Nordisk’s mega-blockbuster diabetes drug.